Shandong Xinhua to Convene 28 April 2026 Board Meeting for Q1 Results Review

Bulletin Express04-15

Shandong Xinhua Pharmaceutical Company Limited announced that its board of directors will meet at 9:30 a.m. on Tuesday, 28 April 2026, in the company’s conference room at No. 1 Lutai Avenue, Hi-tech District, Zibo, Shandong, China.

The agenda comprises: 1. Review and approval of the unaudited consolidated results for the three months ended 31 March 2026. 2. Discussion of other business matters, if any.

Board composition as of 15 April 2026 includes: • Executive Directors: He Tongqing (Chairman), Xu Wenhui, Hou Ning • Independent Non-executive Directors: Pan Guangcheng, Zhu Jianwei, Ling Peixue, Cheung Ching Ching (Daisy) • Non-executive Director: Zhang Chengyong

The company has not provided additional financial figures or performance metrics in this notice; those details are expected upon release of the first-quarter results following the scheduled meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment